News 2021

PRESS RELEASE: Generating recommendations for the design, analysis and interpretation of patient- reported outcome (PRO) data for cancer clinical trials: the launch of SISAQOL-IMI

2025-03-12T15:42:37+01:00

PRESS RELEASE: Generating recommendations for the design, analysis and interpretation of patient- reported outcome (PRO) data for cancer clinical trials: the launch of SISAQOL-IMI2025-03-12T15:42:37+01:00

Collaborating for consensus

2025-03-12T15:43:56+01:00

Collaborating for consensus2025-03-12T15:43:56+01:00

Read our systematic review on patient-reported outcomes in metastatic breast cancer

2025-03-12T15:45:16+01:00

Read our systematic review on patient-reported outcomes in metastatic breast cancer2025-03-12T15:45:16+01:00

The SISAQOL initiative during the 5th EORTC Quality of Life Conference in Brussels

2025-03-12T15:45:46+01:00

The SISAQOL initiative during the 5th EORTC Quality of Life Conference in Brussels2025-03-12T15:45:46+01:00

The SISAQOL-IMI Project has received funding from the Innovative Health Initiative 2 joint undertaking under grant agreement No 945052. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.